CYSTATIN C - ANVISA Registration 80158990243

Access comprehensive regulatory information for CYSTATIN C in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80158990243 and manufactured by RANDOX LABORATORIES LTD.. The registration is held by RANDOX BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC., SPINREACT S.A.U., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80158990243
Registration Details
ANVISA Registration Number: 80158990243
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

FAMĂŤLIA CONTROLE DE CISTATINA C
Risk Class II

Registration Details

80158990243

25351204163201590

05257628000190

Company Information

Northern Ireland (United Kingdom)
PT: IRLANDA DO NORTE (REINO UNIDO)

Dates and Status

Jun 08, 2015

VIGENTE

09/18/2025 19:00:01